EP17.54: Assessment of the angiogenic ratio versus glycosylated fibronectin in predicting adverse neonatal outcome in women with suspected pre‐eclampsia

Adverse Outcome Pathway
DOI: 10.1002/uog.28711 Publication Date: 2024-09-09T14:24:04Z